![Dolca Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dolca Thomas
Director/Board Member at
UCB
Profile
Dolca Thomas is Director at Ventus Therapeutics, Inc. since 2021 and Director at Ventus Therapeutics U.S., Inc. since 2021.
Also holds the position of Independent Director at UCB SA starting in 2024 and Senior Advisor & Venture Partner at Samsara BioCapital LLC since 2023.
Formerly Director-Global Clinical Development at Bristol Myers Squibb Co. from 2008 to 2012, Director at PML Computer Centre Pty Ltd. from 2010 to 2015, Director at Juvenile Diabetes Research Foundation from 2012 to 2015, Independent Director at Allakos, Inc. from 2023 to 2025, Independent Director at Chinook Therapeutics, Inc. from 2020 to 2023, Vice President-Clinical Development at Pfizer Inc. from 2012 to 2016, Chief Medical Officer at Principia Biopharma, Inc. from 2018 to 2020, VP & Global Head-Translational Medicine at Roche Group from 2016 to 2018, and Chief Medical Officer, EVP-Research & Development at Equillium, Inc. from 2021 to 2022.
Education includes an undergraduate degree from Cornell University conferred in 1992 and a doctorate from Weill Cornell Medical College conferred in 1997.
Dolca Thomas active positions
| Companies | Position | Start |
|---|---|---|
| UCB | Director/Board Member | 2024-04-24 |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Director/Board Member | 2021-08-31 |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Wholesales drugs | Director/Board Member | 2021-12-06 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 2023-02-28 |
Former positions of Dolca Thomas
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | Director/Board Member | 2025-05-14 |
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 2023-08-10 |
| EQUILLIUM, INC. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
| PRINCIPIA BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2020-09-27 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 2018-08-31 |
Training of Dolca Thomas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
PML Computer Centre Pty Ltd.
 PML Computer Centre Pty Ltd. Electronics/Appliance StoresRetail Trade Provides retail and corporate IT products and services | Retail Trade |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Juvenile Diabetes Research Foundation
 Juvenile Diabetes Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates organization to treat and prevent diabetes | Commercial Services |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
- Stock Market
- Insiders
- Dolca Thomas
